The FDA authorized a second booster dose in adults aged 50 years old and older and for those aged 12 years old and older with compromised immune systems.
Automated Drug Delivery Systems, such as the Pharmaself24 system, allows for refill prescriptions to be made available for pickup by patients through a secure exterior portal.
This is the first product launch under the previously announced exclusive licensing agreement between Nevakar Injectables, and Endo's subsidiary, Endo Ventures.